MRUS Merus N.V.

19.97
0  0%
Previous Close 20.00
Open 20.21
Price To book 4.74
Market Cap 321.10M
Shares 16,079,000
Volume 19,361
Short Ratio 0.31
Av. Daily Volume 50,774

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1/2 interim data due at ASCO June 5, 2017. Abstract 2522.
MCLA-128
Breast cancer
Phase 1/2 top-line data due 2H 2017.
MCLA-128
Solid tumors
Phase 1/2 interim data due 2H 2017.
MCLA-117
Acute myeloid leukemia (AML)